Loading
Synektik S.A. Stock: price and insider trades · Poland
Synektik S.A.: what insiders have been doing
Synektik S.A. is a Health Care company. Its directors and officers file their transactions with KNF. From 22 October 2025 to 22 October 2026, the disclosure feed for Synektik S.A. logged 23 filings by 3 insiders.
There is no open-market purchase to report; the filings show 2 sales worth €147.0M by 2 insiders. The largest single trade was a sale of €97.2M by Książek Holding spółka z ograniczoną odpowiedzialnością, published on 17 June 2026.
Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives.
Across the 553 companies tracked on its exchange, the median is 3 filings; at 23 filings, this issuer sits above that mark. Since 2026, the database holds no purchases and 2 sales by insiders of the company.
Source: insider filings from KNF. Past trades are no guide to future returns.
Insider Decl.
23
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€147M
2 ops. · all time
Who traded when
BuySaleKsiążek Holding spółka z ograniczoną odpowiedzialnością1 sale
Melhus Company Ltd.1 sale
Analyst consensus: bullish or bearish?
Analysts rate Synektik S.A. Buy (bullish), based on 5 analysts. Average price target: PLN 373.00.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 7,402 of 26,280 companies
62.5
score / 100
Value45
Quality81
FCF yld2.0%
Earn yld3.5%
EV/EBITDA16.8x
ROE218%
Gross mgn36%
Net mgn15%
Debt/EBITDA0.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended September 2025 · cache
PLN 348.60
Analyst consensus
5 analystsBuy
PLN 323.00Target PLN 373.00(+7%)PLN 419.00
Income statement
RevenuePLN 681.6M
Gross profitPLN 243.6M36% margin
EBITDAPLN 179.6M26% margin
Net incomePLN 102.9M44.8% margin
Valuation
PER (trailing)16.8x
PER (forward)16.7x
P/Book13.9x
Beta0.40
Balance sheet & cash
Market capPLN 3B
Total debtPLN 40.9M
Free Cash FlowPLN 60.9M
Debt / Equity19%
Profitability & ownership
ROE217.6%
ROA29.2%
% insiders16.8%
% institutions17.2%
Last declaration on 21 August 2026
Declarations23 total
615,000 shares@ PLN 350.007.62% mcap100.0% of flowShareWSEKNF:node/735222
▼
Executives
413M PLN0KNF
●
Executives
0KNF
●
Executives
0KNF
●
Executives
0KNF
●
Executives
0KNF
●
Executives
0KNF
●
Executives
0KNF
●
Executives
0KNF
●
Executives
0KNF
●
Executives
0KNF
●
Executives
0KNF
●
Executives
0KNF
●
Executives
0KNF
●
Executives
0KNF
●
Executives
0KNF
●
Executives
0KNF
●
Executives
0KNF
●
Executives
0KNF
●
Executives
0KNF
●
Executives
0KNF
●
Executives
0KNF
●
Executives
0KNF
23 of 23 declarations
About Synektik S.A.
Synektik S.A. is a company specializing in the healthcare and pharmaceutical sector. It is listed on the XWAR market.
